Avalo Therapeutics (AVTX) Total Debt (2014 - 2025)
Avalo Therapeutics posted quarterly Total Debt of $370000.0 for Q2 2025, up 2.78% on a QoQ basis from $360000.0 in Q1 2025.
Avalo Therapeutics (AVTX) has 11 years of Total Debt data on file, last reported at $370000.0 in Q2 2025.
- For the quarter ending Q2 2025, Total Debt changed N/A year-over-year to $370000.0; the trailing twelve-month figure through Jun 2025 stood at $370000.0 (changed N/A YoY), and the FY2024 full-year result was $360000.0, changed N/A from the prior year.
- Total Debt for Q2 2025 stood at $370000.0, up from $360000.0 in the prior quarter.
- Across five years, Total Debt topped out at $32.8 million in Q4 2021 and bottomed at $360000.0 in Q4 2024.
- The 5-year median for Total Debt is $12.0 million (2022), against an average of $11.6 million.
- Peak annual rise in Total Debt reached 58.93% in 2022, while the deepest fall reached 58.93% in 2022.
- A 5-year view of Total Debt shows it stood at $32.8 million in 2021, then plunged by 58.93% to $13.5 million in 2022, then slipped by 22.36% to $10.5 million in 2023, then slumped by 96.56% to $360000.0 in 2024, then rose by 2.78% to $370000.0 in 2025.
- The last three Total Debt figures came in at $370000.0 (Q2 2025), $360000.0 (Q1 2025), and $360000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 370,000.00 |
| Mar 31, 2025 | 360,000.00 |
| Dec 31, 2024 | 360,000.00 |
| Mar 31, 2023 | 10.47 Mn |
| Dec 31, 2022 | 13.49 Mn |
| Sep 30, 2022 | 16.50 Mn |
| Jun 30, 2022 | 18.71 Mn |
| Dec 31, 2021 | 32.83 Mn |
| Sep 30, 2019 | 15.30 Mn |
| Jun 30, 2019 | 15.81 Mn |
| Mar 31, 2019 | 16.51 Mn |
| Dec 31, 2018 | 15.19 Mn |
| Sep 30, 2018 | 16.31 Mn |
| Jun 30, 2018 | 15.43 Mn |
| Mar 31, 2018 | 15.42 Mn |
| Jun 30, 2017 | 607,598.00 |
| Mar 31, 2017 | 1.49 Mn |
| Dec 31, 2016 | 2.35 Mn |
| Sep 30, 2016 | 3.19 Mn |
| Jun 30, 2016 | 4.00 Mn |
| Mar 31, 2016 | 4.79 Mn |
| Dec 31, 2015 | 5.56 Mn |
| Sep 30, 2015 | 6.32 Mn |
| Dec 31, 2014 | 7.21 Mn |